Corrigendum to “Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus” [Eur. J. Pharmacol. 728 (5 April 2014) 128–134] (Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus (2014) 728 (128–134), (S0014299914000995), (10.1016/j.ejphar.2014.01.063));Cardioprotective effects of magnesium valproate in type 2 diabetes mellitus

European Journal of Pharmacology

Volumn 728, Issue 1, 2014, Pages 128-134

  Patel, Bhoomika M ^a   Raghunathan, Suchi ^a   Porwal, Urvashi ^a  

^a NIRMA UNIVERSITY   (India)

Author keywords

Cardiovascular complications; HDAC; Magnesium valproate; Type 2 diabetes mellitus

Indexed keywords

ANTIDIABETIC AGENT; C REACTIVE PROTEIN; COLLAGEN; CREATINE KINASE; LACTATE DEHYDROGENASE; STREPTOZOCIN; VALPROATE MAGNESIUM; CARDIOTONIC AGENT; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DRUG MECHANISM; DYSLIPIDEMIA; FEMALE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HEMODYNAMIC PARAMETERS; HISTOPATHOLOGY; HYPERGLYCEMIA; HYPOINSULINEMIA; MALE; NEWBORN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DRUG EFFECTS; FIBROSIS; HEMODYNAMICS; METABOLISM; PATHOLOGY; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; CARDIOTONIC AGENTS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; FEMALE; FIBROSIS; HEMODYNAMICS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; STREPTOZOCIN; VALPROIC ACID;

EID: 84894349559     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2023.175900     Document Type: Erratum

References (36)

1. A. Advani, Q. Huang, K. Thai, S.L. Advani, K.E. White, D.J. Kelly, D.A. Yuen, K.A. Connelly, P.A. Marsden, and R.E. Gilbert Long-term administration of the histone deacetylase inhibitor ovrinostat attenuates Renal injury in experimental diabetes through an endothelial nitric oxide synthase-dependent mechanism Am. J. Pathol. 178 2011 2205 2214
2. K.A. Amin, and M. Nagy Effect of Carnitine and herbal mixture extract on obesity induced by high fat diet in rats Diabetol. Metab. Syndr. 1 2009 1 17
3. C.L. Antos, T.A. McKinsey, M. Dreitz, L.M. Hollingsworth, C.L. Zhang, K. Schreiber, H. Rindt, R.J. Gorczynski, and E.N. Olson Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors J. Biol. Chem. 278 2003 28930 28937
4. E. Beutler, O. Duron, and B.M. Kelly Improved method for the determination of blood glutathione J. Lab. Clin. Med. 61 1963 882 888
5. S. Bhagyalakshmi, H. Nagaraja, B. Anupama, B. Ramesh, A. Prabha, M. Niranjan, and A. Shreedhara Effect of supervised integrated exercise on heart rate variability in type 2 diabetes mellitus Kardiol. Pol. 65 2007 363 368
6. M.S. Bhatia, S. Srivastava, G. Rajender, and P. Kumar Magnesium valproate Delhi Psychiatry J. 12 2009 126 132
7. J. Cardinale, S. Sriramula, R. Pariaut, A. Guggilam, N. Mariappan, C.M. Elks, and J. Francis HDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats Hypertension 56 2010 437 444
8. S.V. Chittur, N. Sangster-Guity, and P.J. McCormick Histone deacetylase inhibitors: a new mode for inhibition of cholesterol metabolism BMC Genomics 9 2008 507
9. D.P. Christensen, M. Dahllöf, M. Lundh, D.N. Rasmussen, M.D. Nielsen, N. Billestrup, L.G. Grunnet, and T. mandrup-Poulsen Histone deacetylase (HDAC) inhibition as a novel treatment for diabetes mellitus Mol. Med. 17 2011 378 390
10. C. Daosukho, Y. Chen, T. Noel, P. Sompol, R. Nithipongvanitch, J.M. Velez, T.D. Oberley St, and D.K. Clair Phenylbutyrate, a histone deacetylase inhibitor, protects against Adriamycin-induced cardiac injury Free Radical Biol. Med. 42 2007 1818 1825
11. H. Farhangkhoee, A. Khan, H. Kaur, X. Xin, S. Chen, and S. Chakrabarti Vascular endothelial dysfunction in diabetic cardiomyopathy: pathogenesis and potential treatment targets Pharmacol. Ther. 111 2006 384 399
12. F. Giacco, and M. Brownlee Oxidative stress and diabetic complications Circ. Res. 106 2010 1449 1458
13. A.M. Grabiec, P.P. Tak, and K.A. Reedquist Histone deacetylase inhibitors suppress IL-6 production by rheumatoid arthritis firoblast-like synoviocytes and macrophages via modulation of mRNA stability rather than blockade of NF-κB signalling Ann. Rheum. Dis. 70 2011 A30 A31
14. Z.S. Hakim, B.K. Patel, and R.K. Goyal Effects of chronic ramipril treatment in streptozotocin-induced diabetic rats Indian J. Physiol. Pharmacol. 41 1997 353 360
15. S.A. Hayat, B. Patel, R.S. Khattar, and R Malik Diabetic cardiomyopathy: mechanism, diagnosis and treatment Clin. Sci. 107 2004 539 557
16. T. Ichiyama, K. Okada, J.M. Lipton, T. Matsubara, T. Hayashi, and S. Furukawa Sodium valproate inhibits production of TNF-α and IL-6 and activation of NF-Κb Brain Res. 857 2000 246 251
17. H. Kee, I.S. Sohn, K.I. Nam, J.E. Park, Y.R. Qian, Z. Yin, Y. Ahn, M.H. Jeong, Y.J. Bang, N. Kim, J.K. Kim, K.K. Kim, J.A. Epstein, and H. Kook Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding Circulation 113 2006 51 59
18. H.J. Kee, I.S. Sohn, K.I. Nam, J. Park, Y.R. Qian, Z. Yin, Y. Ahn, M.H. Jeong, Y.J. Bang, N. Kim, J.K. Kim, K.K. Kim, J.A. Epstein, and H Kook Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding Circulation 113 2006 51 59
19. T. Lee, T. Lin, and N.C. Chang Inhibition of histone deacetylase on ventricular remodeling in infarcted rats Am. J. Physiol. Heart. Circ. Physiol. 293 2007 H968 H977
20. O.H. Lowry, N.J. Rosenbrough, A.L. Farr, and R.J. Randall Protein measurement with folin phenol reagent J. Biol. Chem. 193 1951 265 275
21. I. Manabe, T. Shindo, and R. Nagai Gene expression in ïbroblasts and ïbrosis: involvement in cardiac hypertrophy Circ. Res. 91 2002 1103 1113
22. T.A. McKinsey Targeting inflammation in heart failure with histone deacetylase ihibitors Mol. Med. 17 2011 434 441
23. M.M. Mihaylova, D.S. Vasquez, K. Ravnskjaer, P.D. Denechaud, R.T. Yu, J.G. Alvarez, M. Downes, R.M. Evans, M. Montminy, and R.J. Shaw Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis Cell 145 2011 607 621
24. H.P. Misra, and I. Frodvich The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase J. Biol. Chem. 247 1972 3170 3175
25. D. Nehar, C. Mauduit, F. Boussouar, and M. Benahmed Interleukin 1α stimulates lactate dehydrogenase A expression and lactate production in cultured porcine Sertoli cells Biol. Reprod. 59 1998 1425 1432
26. H. Ohkawa, N. Ohishi, and K. Yagi Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction Anal. Biochem. 95 1979 351 358
27. J. Op den Buijs, Z. Miklos, N.A. van Riel, C.M. Prestia, O. Szenczi, A. Toth, G.J. Van der Vusse, C. Szabo, and T. Ivanics β-Adrenergic activation reveals impaired cardiac calcium handling at early stage of diabetes Life Sci. 76 2005 1083 1098
28. M. Pang, and S. Zhuang Histone deacetylase: a potential therapeutic target for fibrotic disorders J. Pharmacol. Exp. Ther. 335 2010 266 272
29. P. Pasupathi, Y.Y. Rao, J. Farook, G. Saravanan, and G. Bakthavanthsalam Oxidative stress and cardiac biomarkers in patients with acute myocardial infarction Eur. J. Sci. Res. 27 2009 275 285
30. P.M. Ridker High-sensitivity C-reactive protein and cardiovascular risk: rational for screening and primary prevention Am. J. Cardiol. 21 2003 17K 22K
31. S.G. Royce, W. Dang, K. Ververis, N.D. De Sampayo, A. El-Osta, M.L. Tang, and T.C. Karagiannis Protective effects of valproic acid against airway hyperresponsiveness and airway remodeling in a mouse model of allergic airways disease Epigenetics 6 2011 1463 1470
32. C. Tourrel, D. Bailbe, M.J. Meile, m. Kergoat, and B. Portha Glucagon-like peptide-1 and exendin-4 stimulate b-cell neogenesis in streptozotocin-treated newborn rats resulting in persistently improved glucose homeostasis at adult age Diabetes 50 2001 1562 1570
33. M. Tsimaratos, T.C. Coste, A. Djemli-Shipkolye, P. Vague, G. Pieroni, and D. Raccah Linolenic acid restores renal medullary thick ascending limb Na+K+ATPase activity in diabetic rats J. Nutr. 131 2001 3160 3165
34. R.K. Vats, V. Kumar, A. Koyhari, A. Mital, and U. Ranmachandran Emerging targets for diabetes Curr. Sci. 88 2000 241 247
35. T.M. Vondriska, and Y.A. Wang New (heat) shocking player in cardiac hypertrophy Circ. Res. 103 2008 1194 1196
36. A. Yilmaz, K. Yalta, O.O. Turgut, M.B. Yilmaz, A. Ozyol, O. Kendirlioglu, F. Karadas, and I. Tandogan Clinical importance of elevated CK-MB and troponin I levels in congestive heart failure Adv. Ther. 23 2006 1060 1067